reglab/housing_qa huggingface dataset:
MT Code § 50-31-404 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 31. Montana Food, Drug, and Cosmetic Act|Part 4. Cosmetics|50-31-404. Term hair dye not to include eyelash or eyebrow dyes

  50-31-404. Term hair dye not to include eyelash or eyebrow dyes. For the purpose of 50-31-401(5) and 50-31-403, the term "hair dye" shall not include eyelash dyes or eyebrow dyes.   History: En. Sec. 18, Ch. 307, L. 1967; R.C.M. 1947, 27-718(part).
MT Code § 50-31-502 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 31. Montana Food, Drug, and Cosmetic Act|Part 5. Prohibited Acts, Penalties, and Remedies|50-31-502. Unlawful labeling of products resembling honey

  50-31-502. Unlawful labeling of products resembling honey. It is unlawful for any person to sell or offer for sale any product which is in semblance of honey and which is labeled, advertised, or otherwise represented to be honey if it is not honey.   History: En. Sec. 3, Ch. 307, L. 1967; amd. Sec. 2, Ch. 171, L. 1971; amd. Sec. 2, Ch. 114, L. 1974; amd. Sec. 9, Ch. 403, L. 1977; R.C.M. 1947, 27-703(part).
MT Code § 50-31-503 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 31. Montana Food, Drug, and Cosmetic Act|Part 5. Prohibited Acts, Penalties, and Remedies|50-31-503. Prosecution of minor violations not required

  50-31-503. Prosecution of minor violations not required. Nothing in this chapter shall be construed as requiring the department to report for the institution of proceedings under this chapter minor violations of this chapter whenever the department believes that the public interest will be adequately served in the circumstances by a suitable written notice of warning.   History: En. Sec. 8, Ch. 307, L. 1967; R.C.M. 1947, 27-708.
MT Code § 50-31-504 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 31. Montana Food, Drug, and Cosmetic Act|Part 5. Prohibited Acts, Penalties, and Remedies|50-31-504. Notice and hearing required prior to prosecution

  50-31-504. Notice and hearing required prior to prosecution. Before a violation of this chapter is reported to a state or county attorney for the institution of a criminal proceeding, the person against whom the proceeding is contemplated must be given appropriate notice and an opportunity to present the person's views before the department or its designated agent, either orally or in writing and either in person or by attorney, with regard to the contemplated proceeding.   History: En. Sec. 7, Ch. 307, L. 1967; amd. Sec. 2, Ch. 187, L. 1977; R.C.M. 1947, 27-707(part); amd. Sec. 1843, Ch. 56, L. 2009.
MT Code § 50-31-505 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 31. Montana Food, Drug, and Cosmetic Act|Part 5. Prohibited Acts, Penalties, and Remedies|50-31-505. Duty of state or county attorneys to prosecute

  50-31-505. Duty of state or county attorneys to prosecute. Each state attorney or county attorney to whom the department reports a violation of this chapter shall cause appropriate proceedings to be instituted in the proper courts without delay and to be prosecuted in the manner required by law.   History: En. Sec. 7, Ch. 307, L. 1967; amd. Sec. 2, Ch. 187, L. 1977; R.C.M. 1947, 27-707(part).
MT Code § 50-31-506 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 31. Montana Food, Drug, and Cosmetic Act|Part 5. Prohibited Acts, Penalties, and Remedies|50-31-506. Penalties

  50-31-506. Penalties. (1) Any person who violates any of the provisions of 50-31-204, 50-31-208, 50-31-313, 50-31-315, 50-31-501, or 50-31-502 is guilty of a misdemeanor and shall on conviction thereof be subject to imprisonment for not more than 3 months, a fine of not more than $250, or both such imprisonment and fine.   (2) If the violation is committed after a conviction of such person under this section has become final, such person shall be subject to imprisonment for not more than 6 months, a fine of not more than $500, or both such imprisonment and fine.   History: En. Sec. 5, Ch. 307, L. 1967; R.C.M. 1947, 27-705(a); amd. Sec. 3, Ch. 456, L. 1979; amd. Sec. 5, Ch. 95, L. 1981.
MT Code § 50-31-507 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 31. Montana Food, Drug, and Cosmetic Act|Part 5. Prohibited Acts, Penalties, and Remedies|50-31-507. Exceptions to penalties

  50-31-507. Exceptions to penalties. (1) A person is not subject to the penalties of 50-31-506 for having violated 50-31-501(1) or (3) if the person establishes a guaranty or undertaking signed by and containing the name and address of the person residing in the state of Montana from whom the person received in good faith the article to the effect that the article is not adulterated or misbranded within the meaning of this chapter, designating this chapter.   (2) The publisher, radiobroadcast licensee, or agency or medium for the dissemination of an advertisement, except the manufacturer, packer, distributor, or seller of the article to which a false advertisement relates, is not liable under 50-31-506 by reason of the dissemination by the person of the false advertisement, unless the person has refused, on the request of the department, to furnish the department the name and post-office address of the manufacturer, packer, distributor, seller, or advertising agency residing in the state of Montana who causes the person to disseminate the advertisement.   History: En. Sec. 5, Ch. 307, L. 1967; R.C.M. 1947, 27-705(b), (c); amd. Sec. 1844, Ch. 56, L. 2009.
MT Code § 50-31-508 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 31. Montana Food, Drug, and Cosmetic Act|Part 5. Prohibited Acts, Penalties, and Remedies|50-31-508. Injunction to restrain prohibited acts

  50-31-508. Injunction to restrain prohibited acts. In addition to the remedies hereinafter provided, the department is hereby authorized to apply to district court for and such court shall have jurisdiction upon hearing and for cause shown to grant a temporary or permanent injunction restraining any person from violating any provision of 50-31-204, 50-31-208, 50-31-501, or 50-31-502, irrespective of whether or not there exists an adequate remedy at law.   History: En. Sec. 4, Ch. 307, L. 1967; R.C.M. 1947, 27-704; amd. Sec. 4, Ch. 456, L. 1979.
MT Code § 50-31-510 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 31. Montana Food, Drug, and Cosmetic Act|Part 5. Prohibited Acts, Penalties, and Remedies|50-31-510. Condemnation of perishables

  50-31-510. Condemnation of perishables. Whenever the department or any of its authorized agents find in any room, building, vehicle of transportation, or other structure any meat, seafood, poultry, vegetable, fruit, or other perishable article which is unsound or contains any filthy, decomposed, or putrid substance or that may be poisonous or deleterious to health or otherwise unsafe, the article being hereby declared to be a nuisance, the department or its authorized agent shall immediately condemn or destroy the article or in any other manner render the article unsalable as human food.   History: En. Sec. 6, Ch. 307, L. 1967; amd. Sec. 1, Ch. 187, L. 1977; R.C.M. 1947, 27-706(4).
MT Code § 50-32-102 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 1. General Provisions|50-32-102. Uniformity of construction

  50-32-102. Uniformity of construction. This chapter shall be so applied and construed as to effectuate its general purpose to make uniform the law with respect to the subject of this chapter among those other states which enact it.   History: En. Sec. 28, Ch. 412, L. 1973; R.C.M. 1947, 54-326.
MT Code § 50-32-103 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 1. General Provisions|50-32-103. Board to administer chapter

  50-32-103. Board to administer chapter. (1) The board shall administer this chapter and may add drugs to or delete or reschedule all drugs enumerated in the schedules in 50-32-222, 50-32-224, 50-32-226, 50-32-229, or 50-32-232 pursuant to the rulemaking procedures of the Montana Administrative Procedure Act.   (2) The board shall promulgate rules for its administration which are not inconsistent with this chapter and specifically shall levy and the department shall collect reasonable registration fees relating to the registration and control of the manufacture, distribution, and dispensing of dangerous drugs within the state. The maximum fee for any registration shall not exceed $100 per year.   History: En. Secs. 2, 15, Ch. 412, L. 1973; amd. Secs. 2, 5, Ch. 350, L. 1974; R.C.M. 1947, 54-302(part), 54-315.
MT Code § 50-32-104 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 1. General Provisions|50-32-104. Board's authority limited

  50-32-104. Board's authority limited. Authority to control under 50-32-103 does not extend to distilled spirits, liquor, wine, malt beverages, beer, porter, ale, stout, or tobacco.   History: En. Sec. 2, Ch. 412, L. 1973; amd. Sec. 2, Ch. 350, L. 1974; R.C.M. 1947, 54-302(5).
MT Code § 50-32-105 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 1. General Provisions|50-32-105. Board to conduct educational programs

  50-32-105. Board to conduct educational programs. (1) The board shall carry out educational programs designed to prevent and deter misuse and abuse of dangerous drugs.   (2) In connection with these programs, it may:   (a) promote better recognition of the problems of misuse and abuse of dangerous drugs within the regulated industry and among interested groups and organizations;   (b) assist the regulated industry and interested groups and organizations in contributing to the reduction of misuse and abuse of dangerous drugs;   (c) consult with interested groups and organizations to aid them in solving administrative and organizational problems;   (d) evaluate procedures, projects, techniques, and controls conducted or proposed as part of educational programs on misuse and abuse of dangerous drugs;   (e) disseminate the results of research on misuse and abuse of dangerous drugs to promote a better public understanding of what problems exist and what can be done to combat them; and   (f) assist in the education and training of state and local law enforcement officials in their efforts to control misuse and abuse of dangerous drugs.   History: En. Sec. 23, Ch. 412, L. 1973; amd. Sec. 11, Ch. 350, L. 1974; R.C.M. 1947, 54-323(1).
MT Code § 50-32-106 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 1. General Provisions|50-32-106. Board to encourage research

  50-32-106. Board to encourage research. (1) The board shall encourage research on misuse and abuse of dangerous drugs.   (2) In connection with the research and in furtherance of the enforcement of this chapter, it may:   (a) establish methods to assess accurately the effects of dangerous drugs and identify and characterize those with potential for abuse;   (b) make studies and undertake programs of research to:   (i) develop new or improved approaches, techniques, systems, equipment, and devices to strengthen the enforcement of this chapter;   (ii) determine patterns of misuse and abuse of dangerous drugs and the social effects thereof; and   (iii) improve methods for preventing, predicting, understanding, and dealing with the misuse and abuse of dangerous drugs; and   (c) request the department to enter into contracts with public agencies, institutions of higher education, and private organizations or individuals for the purpose of conducting research, demonstrations, or special projects which bear directly on misuse and abuse of dangerous drugs.   (3) The board may authorize persons engaged in research on the use and effects of dangerous drugs to withhold the names and other identifying characteristics of individuals who are the subjects of the research. Persons who obtain this authorization are not compelled in any civil, criminal, administrative, legislative, or other proceeding to identify the individuals who are the subjects of research for which the authorization was obtained.   (4) The board may authorize the possession and distribution of dangerous drugs by persons engaged in research. Persons who obtain this authorization are exempt from state prosecution for possession and distribution of dangerous drugs to the extent of the authorization.   History: En. Sec. 23, Ch. 412, L. 1973; amd. Sec. 11, Ch. 350, L. 1974; R.C.M. 1947, 54-323(2) thru (4).
MT Code § 50-32-201 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-201. General criteria to be considered

  50-32-201. General criteria to be considered. In making a determination regarding a drug, the board shall consider the following:   (1) the actual or relative potential for abuse;   (2) the scientific evidence of its pharmacological effect, if known;   (3) the state of current scientific knowledge regarding the drug;   (4) the history and current pattern of abuse;   (5) the scope, duration, and significance of abuse;   (6) the risk to the public health;   (7) the potential of the drug to produce psychic or physiological dependence liability; and   (8) whether the drug is an immediate precursor of a drug already controlled under this chapter.   History: En. Sec. 2, Ch. 412, L. 1973; amd. Sec. 2, Ch. 350, L. 1974; R.C.M. 1947, 54-302(part).
MT Code § 50-32-202 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-202. Designation of drug as dangerous drug

  50-32-202. Designation of drug as dangerous drug. After considering the factors enumerated in 50-32-201, the board shall make findings with respect thereto, and if it finds the drug has a potential for abuse, it shall designate such drug a dangerous drug in the manner set forth in the Montana Administrative Procedure Act.   History: En. Sec. 2, Ch. 412, L. 1973; amd. Sec. 2, Ch. 350, L. 1974; R.C.M. 1947, 54-302(2).
MT Code § 50-32-203 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-203. Effect of rescheduling under federal law

  50-32-203. Effect of rescheduling under federal law. If any drug is designated, rescheduled, or deleted as a "controlled substance" under federal law and notice thereof is given to the board, the board shall similarly control the drug under this chapter after the expiration of 30 days from publication in the Federal Register of a final order designating a drug as a "controlled substance" or rescheduling or deleting a drug unless, within that 30-day period, the board objects to inclusion, rescheduling, or deletion. In that case, the board shall cause the reasons for objection to be published and afford all interested parties an opportunity to be heard. At the conclusion of the hearing, the department shall publish the board's decision which shall be final unless altered thereafter by the board or by statute. Upon publication of objection to inclusion, rescheduling, or deletion under this chapter by the board, control under this chapter is stayed until the board's decision is published.   History: En. Sec. 2, Ch. 412, L. 1973; amd. Sec. 2, Ch. 350, L. 1974; R.C.M. 1947, 54-302(4).
MT Code § 50-32-204 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-204. Immediate precursors

  50-32-204. Immediate precursors. If the board designates a drug as an immediate precursor, drugs which are precursors of the controlled precursor shall not be subject to control solely because they are precursors of the controlled precursor.   History: En. Sec. 2, Ch. 412, L. 1973; amd. Sec. 2, Ch. 350, L. 1974; R.C.M. 1947, 54-302(3).
MT Code § 50-32-205 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-205. Nonprescription drugs not to be scheduled

  50-32-205. Nonprescription drugs not to be scheduled. The board shall exclude any nonnarcotic drug from a schedule if the drug may, under the Federal Food, Drug, and Cosmetic Act, be lawfully sold over the counter without a prescription.   History: En. Sec. 2, Ch. 412, L. 1973; amd. Sec. 2, Ch. 350, L. 1974; R.C.M. 1947, 54-302(6); amd. Sec. 5, Ch. 472, L. 1989; amd. Sec. 1, Ch. 61, L. 2009.
MT Code § 50-32-206 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-206. Use of names of scheduled drugs

  50-32-206. Use of names of scheduled drugs. The dangerous drugs listed or to be listed in the schedules in 50-32-222, 50-32-224, 50-32-226, 50-32-229, and 50-32-232 are included by whatever official, common, usual, chemical, or trade name designated.   History: En. Sec. 3, Ch. 412, L. 1973; amd. Sec. 3, Ch. 350, L. 1974; R.C.M. 1947, 54-303.
MT Code § 50-32-207 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-207. Order forms for drugs in Schedules I and II

  50-32-207. Order forms for drugs in Schedules I and II. Dangerous drugs in Schedules I and II shall be distributed by a registrant to another registrant only pursuant to an order form. Compliance with the provisions of federal law respecting order forms shall be deemed compliance with this section unless the board prescribes particular forms to be used.   History: En. Sec. 21, Ch. 412, L. 1973; R.C.M. 1947, 54-321.
MT Code § 50-32-208 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-208. Prescription and medical requirements for scheduled drugs -- penalty

  50-32-208. Prescription and medical requirements for scheduled drugs -- penalty. (1) (a) No dangerous drug in Schedule II may be dispensed without the written or electronic prescription of a practitioner.   (b) In emergency situations, as defined by rule of the board, Schedule II drugs may be dispensed upon a practitioner's oral prescription reduced promptly to writing and filed by the pharmacy. Prescriptions must be retained in conformity with the requirements of 50-32-309. A prescription for a Schedule II drug may not be refilled.   (2) A dangerous drug included in Schedule III or IV, which is a prescription drug as determined under the federal or Montana food, drug, and cosmetic acts, may not be dispensed without a written, electronic, or oral prescription of a practitioner. The prescription may not be filled or refilled more than 6 months after the date of the prescription or be refilled more than five times unless renewed by the practitioner.   (3) A dangerous drug included in Schedule V may not be distributed or dispensed other than for a medical purpose.   (4) A person who violates the provisions of this section is guilty of a misdemeanor and upon conviction may be fined an amount not to exceed $1,000 or be imprisoned in the county jail for a term not to exceed 1 year, or both fined and imprisoned.   History: En. Sec. 22, Ch. 412, L. 1973; amd. Sec. 10, Ch. 350, L. 1974; R.C.M. 1947, 54-322; amd. Sec. 13, Ch. 37, L. 1979; amd. Sec. 13, Ch. 379, L. 1981; amd. Sec. 3, Ch. 206, L. 2015.
MT Code § 50-32-209 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-209. Republication of schedules

  50-32-209. Republication of schedules. The board shall revise and the department shall republish additions, deletions, or other changes to the schedules of dangerous drugs at times determined by the board. For the purposes of this section, the mandate to republish additions, deletions, or other changes is satisfied by publication in the Administrative Rules of Montana pursuant to Title 2, chapter 4.   History: En. Sec. 14, Ch. 412, L. 1973; amd. Sec. 4, Ch. 350, L. 1974; R.C.M. 1947, 54-314; amd. Sec. 14, Ch. 379, L. 1981; amd. Sec. 1, Ch. 113, L. 1997.
MT Code § 50-32-210 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-210. through 50-32-220 reserved

  50-32-210 through 50-32-220 reserved.
MT Code § 50-32-221 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-221. Criteria for placement of drug in Schedule I

  50-32-221. Criteria for placement of drug in Schedule I. The board shall place a drug in Schedule I if it finds that the drug:   (1) has high potential for abuse; and   (2) has no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.   History: En. Sec. 4, Ch. 412, L. 1973; R.C.M. 1947, 54-304.
MT Code § 50-32-223 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-223. Criteria for placement of drug in Schedule II

  50-32-223. Criteria for placement of drug in Schedule II. The board shall place a drug in Schedule II if it finds that:   (1) the drug has high potential for abuse;   (2) the drug has currently accepted medical use in treatment in the United States or currently accepted medical use with severe restrictions; and   (3) the abuse of the drug may lead to severe psychic or physical dependence.   History: En. Sec. 6, Ch. 412, L. 1973; R.C.M. 1947, 54-306.
MT Code § 50-32-225 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-225. Criteria for placement of drug in Schedule III

  50-32-225. Criteria for placement of drug in Schedule III. The board shall place a drug in Schedule III if it finds that:   (1) the drug has a potential for abuse less than the drugs listed in Schedules I and II;   (2) the drug has currently accepted medical use in treatment in the United States; and   (3) abuse of the drug may lead to moderate or low physical dependence or high psychological dependence.   History: En. Sec. 8, Ch. 412, L. 1973; R.C.M. 1947, 54-308.
MT Code § 50-32-227 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-227. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III

  50-32-227. Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III. The board may except by rule any compound, mixture, or preparation containing any stimulant or depressant drug listed in 50-32-226(1) and (2) from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the drugs which have a stimulant or depressant effect on the central nervous system.   History: En. Sec. 9, Ch. 412, L. 1973; R.C.M. 1947, 54-309(5).
MT Code § 50-32-228 (2021)
2021 Montana Code Annotated|Title 50. Health and Safety|Chapter 32. Controlled Substances|Part 2. Scheduling of Dangerous Drugs|50-32-228. Criteria for placement of drug in Schedule IV

  50-32-228. Criteria for placement of drug in Schedule IV. The board shall place a drug in Schedule IV if it finds that:   (1) the drug has a low potential for abuse relative to drugs in Schedule III;   (2) the drug has currently accepted medical use in treatment in the United States; and   (3) abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in Schedule III.   History: En. Sec. 10, Ch. 412, L. 1973; R.C.M. 1947, 54-310.